s-amlodipine brands
10 registered brands containing s-amlodipine in Kenya.
s-amlodipine
PubChem CID 9822750Molecular formula: C20H25ClN2O5
Levamlodipine blocks the transmembrane influx of calcium through L-type calcium channels into the vascular and cardiac smooth muscles resulting in vasodilation and a subsequent decrease in blood pressure. Levamlodipine inhibits calcium influx in vascular smooth muscle to a greater degree than in cardiac muscle, leading to decreased peripheral vascular resistance and lowered blood pressure. In vitro studies have shown a negative inotropic effect but this is unlikely to be clinically relevant.
Source: PubChem (NCBI) ยท compound 9822750
All countries
Kenya
Tanzania
Rwanda
Zambia
Uganda
Malawi
South Africa
Zimbabwe
Nigeria
Ghana
Botswana
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| ESAM 2.5 2.5 MG |
Medox Pharmaceuticals | Registered | Kenya |
| ESAM 5 5 MG |
Medox Pharmaceuticals | Registered | Kenya |
| ESEM 2.5 EACH UNCOATED TABLET CONTAINS 2.5 MG |
Simba Pharmaceuticals | Registered | Kenya |
| ESEM 5 EACH UNCOATED TABLET CONTAINS 5MG |
Simba Pharmaceuticals | Registered | Kenya |
| MYLOVASC 2.5MG TABLETS S-AMLODIPINE BESILATE 2.5MG |
Wessex Pharmaceuticals | Registered | Kenya |
| MYLOVASC 2.5MG TABLETS Tablet |
Prisma Pharma FZE | Retained | Kenya |
| MYLOVASC 5 MG 5MG |
Pharma Specialities | Registered | Kenya |
| MYLOVASC 5 MG TABLETS S-AMLODIPINE BESILATE 5MG |
Wessex Pharmaceuticals | Registered | Kenya |
| MYLOVASC 5 MG TABLETS Tablet |
Prisma Pharma FZE | Retained | Kenya |
| MYLOVASC 5 MG TABLETS Tablet |
Prisma Pharma FZE | Retained | Kenya |